Your browser doesn't support javascript.
loading
Differential treatment effect between younger and older adults for new cancer therapies in solid tumors supporting US Food and Drug Administration approval between 2010 and 2021.
Wilson, Brooke E; Desnoyers, Alexandra; Nadler, Michelle B; Amir, Eitan; Booth, Christopher M.
Affiliation
  • Wilson BE; Department of Oncology, Queen's University, Kingston, Ontario, Canada.
  • Desnoyers A; Division of Cancer Care and Epidemiology, Queen's Cancer Research Institute, Kingston, Ontario, Canada.
  • Nadler MB; School of Population Health, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia.
  • Amir E; Centre Hospitalier Universitaire de Quebec-Université Laval, Hôpital Saint-Sacrement, Centre des Maladies du Sein Deschênes-Fabia, Quebec, Quebec, Canada.
  • Booth CM; Department of Medical Oncology and Haematology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada.
Cancer ; 129(20): 3318-3325, 2023 10 15.
Article in En | MEDLINE | ID: mdl-37340792
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Agents Type of study: Clinical_trials / Observational_studies / Risk_factors_studies / Systematic_reviews Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Cancer Year: 2023 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Agents Type of study: Clinical_trials / Observational_studies / Risk_factors_studies / Systematic_reviews Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Cancer Year: 2023 Document type: Article Affiliation country: